In today's Pharmaceutical Executive Daily, the FDA approves Gilead's Trodelvy for the first-line treatment of metastatic ...
In today's Pharmaceutical Executive Daily, AbbVie announces a $10.9 billion agreement to acquire Apogee Therapeutics, adding ...
CHMP recommended EU marketing authorization for pirtobrutinib in adult CLL across all therapy lines, regardless of prior BTK inhibitor treatment history. BRUIN CLL-313 and CLL-314 supported meaningful ...
Capvaxive uniquely adds eight adult-predominant invasive serotypes absent from other approved pneumococcal vaccines, ...
Approval establishes sacituzumab govitecan as a first-line option across PD-L1 strata, including monotherapy when checkpoint inhibitors are unsuitable and combination therapy for PD-L1 CPS ≥10 tumors.
They want to make sure we've got more control over that supply chain, so DARPA and the federal government are really ...
FDA approved Utebzi, an oral carbapenem antibiotic developed by GSK in partnership with Spero Therapeutics, for the treatment ...
Clinical Affairs plays a central role in ensuring that CGM promotional claims are accurate, evidence-based, and compliant. By ...
In January of this year, Novavax announced a partnership that would provide its Matrix-M adjuvant technology to Pfizer for ...
Silvia Taylor of Novavax details how the company leverages its expertise in vaccine development to build partnerships across ...
As Connecticut moves to rein in private equity's playbook in hospital deals, pharma and life sciences leaders face a parallel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results